Journal Club: Review of Focused Recommendations for the Management of MASLD
Thank you to Madrigal for your support on this Journal Club Review video module.This journal club review explores the 2025 focused recommendations for the management of metabolic dysfunction–associate...
16 Joulu 202510min
Medication Review: Resmetirom: Core Efficacy Data and Patient Selection Considerations
Thank you to Madrigal for your support of this Medication Review Video Module.Discover how Resmetirom is reshaping the treatment landscape for metabolic dysfunction–associated steatohepatitis (MASH) i...
9 Joulu 202510min
FAQ: What Are The Functional And Prognostic Differences Between Fibrosis F3 And F4 Patients?
Thank you to Madrigal for your support on this FAQ Video Module.In this episode, Christina Hanson, NP, breaks down the key functional and prognostic differences between fibrosis stage F3 and F4, expla...
2 Joulu 20254min
The Conversation That Matters: Talking to Patients About Obesity and IMIDs
In this final episode of our RhAPP, MAPP, GHAPP, and SDPA crosscast series, expert APPs from dermatology, gastroenterology, rheumatology, and obesity medicine break down the most important conversatio...
1 Joulu 202515min
From Insight to Action: Practical Strategies to Improve Outcomes in Patients with Obesity and IMIDs
In this cross-specialty episode of our RhAPP, GHAPP, MAPP and SDPA collaborative series, leading APPs from dermatology, gastroenterology, rheumatology, and metabolic medicine break down real-world str...
24 Marras 202515min
GHAPPcast: Women of Childbearing Age With IBD
Thank you to AbbVie for your support on this podcast episode.Navigating pregnancy with inflammatory bowel disease (IBD) can bring unique questions, concerns, and misconceptions—especially for women of...
18 Marras 202524min
The Hidden Costs: Obesity’s Role in Suboptimal Outcomes and Healthcare Burden in IMIDs
In this episode of our crosscast series shared across RhAPPcast, GHAPPcast, and Dermcast, we explore the hidden costs of obesity in immune-mediated inflammatory diseases (IMIDs) and how excess adiposi...
17 Marras 202518min
FAQ: How Do You Explain Remission To A Patient?
Thank you to AbbVie for your support on this FAQ Video Module.In this GHAPP FAQ Video Module, Christie Morrison, from Oshi Health and Texas Digestive Disease Consultants, explains how to discuss clini...
13 Marras 20255min
